Opinion

Video

CAR T: A Review of Clinical Data for Second Line Treatments of Large B-Cell Lymphoma

Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.

Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Francine Foss, MD
David C. Fisher, MD